ArticleFrontiers in oncology2026
CFTR functions as a tumor suppressor in adenoid cystic carcinoma and its silencing reveals an associated vulnerability involving the Hsp70 chaperone system.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Adenoid cystic carcinoma is a rare salivary gland malignancy of the head and neck region characterized by perineural invasion, distant metastasis, and a lack of effective targeted therapies. The molecular mechanisms underlying its progression remain poorly understood. Methods: In this study, we identified the cystic fibrosis transmembrane conductance regulator (CFTR) as a consistently downregulated gene in adenoid cystic carcinoma through differential expression analysis of multiple independent transcriptomic cohorts. Functional experiments were performed in SACC-83 and SACC-LM cell lines, including ectopic expression and knockdown of CFTR, RNA sequencing, quantitative polymerase chain reaction, and Western blot analyses. Pharmacological inhibition of Hsp70 using VER155008 and activation of the heat shock response by HSF1A were also assessed for effects on cell viability, migration, invasion, and apoptosis. Subcutaneous xenograft experiments in nude mice were conducted to evaluate tumor growth following stable CFTR knockdown in SACC-LM cells. Results: Preliminary Kaplan-Meier survival analysis demonstrated that low CFTR expression was significantly associated with inferior overall survival, although this finding requires validation in a larger independent cohort. Protein interaction network modeling revealed that CFTR occupies a hub position within a conserved interaction network linking ion channel regulation, protein quality control, and kinase signaling. Functional experiments showed that ectopic expression of CFTR suppressed cell proliferation, migration, and invasion, whereas CFTR knockdown enhanced these malignant phenotypes, supporting a tumor-suppressive role for CFTR in these model systems. RNA sequencing of CFTR-overexpressing cells revealed coordinated downregulation of heat shock protein family members, including HSPA1A, HSPA1B, and HSPA6, with enrichment of pathways related to protein refolding. Quantitative polymerase chain reaction and Western blot analyses confirmed that CFTR expression is inversely associated with Hsp70 family members and MAPK1 (ERK2) at both mRNA and protein levels. Pharmacological inhibition of Hsp70 using VER155008 suppressed cell viability, migration, and invasion in a dose-dependent manner and induced apoptosis, phenocopying the effects of CFTR restoration. Subcutaneous xenograft experiments in nude mice further demonstrated that stable CFTR knockdown in SACC-LM cells markedly accelerated tumor growth. Conversely, activation of the heat shock response by HSF1A promoted proliferation, migration, and invasion, recapitulating the consequences of CFTR loss. Notably, Hsp70 inhibition was accompanied by compensatory upregulation of MAPK1 transcripts, suggesting that CFTR is inversely associated with Hsp70 and MAPK1 through parallel rather than linear mechanisms. Discussion: These findings indicate that CFTR silencing in adenoid cystic carcinoma is accompanied by elevated Hsp70 chaperone expression, and that pharmacological targeting of Hsp70 phenocopies, rather than necessarily mediates, the tumor-suppressive effects of CFTR restoration in the SACC-83 and SACC-LM lineage. Targeting Hsp70 therefore provides a preclinical rationale, rather than direct translational evidence, for further investigation in this otherwise treatment-refractory malignancy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.